Haemonetics Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4050241003
USD
83.81
1.9 (2.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,360.82
1,309.06
1,168.66
993.20
870.46
988.48
967.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,360.82
1,309.06
1,168.66
993.20
870.46
988.48
967.58
Raw Material Cost
645.50
632.52
578.43
515.04
474.85
479.46
510.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.89
16.50
15.88
18.50
12.43
16.74
11.27
Selling and Distribution Expenses
431.85
416.17
373.95
320.93
269.40
284.00
284.65
Other Expenses
5.12
3.57
3.32
2.75
1.93
1.33
2.44
Total Expenditure (Excl Depreciation)
1,138.48
1,100.92
1,001.46
881.95
775.94
793.45
831.24
Operating Profit (PBDIT) excl Other Income
222.3
208.1
167.2
111.19999999999999
94.5
195
136.3
Other Income
1.74
3.97
-0.74
9.60
32.81
0.00
0.00
Operating Profit (PBDIT)
339.67
309.33
259.77
218.60
211.62
305.32
245.76
Interest
9.89
16.50
15.88
18.50
12.43
16.74
11.27
Exceptional Items
-2.13
-43.75
-9.19
-38.72
-41.99
-91.13
-51.44
Gross Profit (PBDT)
715.33
676.54
590.23
478.16
395.62
509.02
456.71
Depreciation
115.59
97.22
93.31
97.75
84.29
110.29
109.42
Profit Before Tax
212.07
151.87
141.40
63.63
72.91
87.15
73.63
Tax
44.39
34.31
26.00
20.25
-6.56
10.63
18.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
167.68
117.56
115.40
43.38
79.47
76.53
55.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
167.68
117.56
115.40
43.38
79.47
76.53
55.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
167.68
117.56
115.40
43.38
79.47
76.53
55.02
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
820.84
959.96
818.00
749.42
731.67
587.11
667.87
Earnings per share (EPS)
3.31
2.29
2.24
0.84
1.55
1.48
1.04
Diluted Earnings per share
3.31
2.29
2.24
0.84
1.55
1.48
1.04
Operating Profit Margin (Excl OI)
16.34%
15.9%
14.31%
11.2%
10.86%
19.73%
14.09%
Gross Profit Margin
24.08%
19.03%
20.08%
16.25%
18.06%
19.97%
18.92%
PAT Margin
12.32%
8.98%
9.87%
4.37%
9.13%
7.74%
5.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 3.95% vs 12.01% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 42.60% vs 1.91% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 10.64% vs 17.24% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -40.00% vs 3.77% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Haemonetics Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,360.82
2,510.60
-1,149.78
-45.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,360.82
2,510.60
-1,149.78
-45.80%
Raw Material Cost
645.50
1,132.00
-486.50
-42.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.89
46.40
-36.51
-78.69%
Selling and Distribution Expenses
431.85
1,136.40
-704.55
-62.00%
Other Expenses
5.12
5.27
-0.15
-2.85%
Total Expenditure (Excl Depreciation)
1,138.48
2,367.50
-1,229.02
-51.91%
Operating Profit (PBDIT) excl Other Income
222.34
143.10
79.24
55.37%
Other Income
1.74
-0.10
1.84
1,840.00%
Operating Profit (PBDIT)
339.67
266.10
73.57
27.65%
Interest
9.89
46.40
-36.51
-78.69%
Exceptional Items
-2.13
-1,181.30
1,179.17
99.82%
Gross Profit (PBDT)
715.33
1,378.60
-663.27
-48.11%
Depreciation
115.59
123.10
-7.51
-6.10%
Profit Before Tax
212.07
-1,084.70
1,296.77
119.55%
Tax
44.39
33.90
10.49
30.94%
Provisions and contingencies
0
0
0.00
Profit After Tax
167.68
-1,118.60
1,286.28
114.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
167.68
-1,118.60
1,286.28
114.99%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
167.68
-1,118.60
1,286.28
114.99%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
820.84
2,934.80
-2,113.96
-72.03%
Earnings per share (EPS)
3.31
-6.50
9.81
150.92%
Diluted Earnings per share
3.31
-6.50
9.81
150.92%
Operating Profit Margin (Excl OI)
16.34%
5.70%
0.00
10.64%
Gross Profit Margin
24.08%
-38.30%
0.00
62.38%
PAT Margin
12.32%
-44.56%
0.00
56.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 136.08 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 3.95% vs 12.01% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 16.77 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 42.60% vs 1.91% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.79 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 10.64% vs 17.24% in Mar 2024

Annual - Interest
Interest 0.99 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -40.00% vs 3.77% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.34%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024